Local Institution - 007-5476 — Washington D.C., District of Columbia

Local Institution - 007-5476 is a clinical research site located in Washington D.C., District of Columbia, United States 20010.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 007-5476 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer.

Sponsors: Mirati Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 007-5476?

Local Institution - 007-5476 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 007-5476 conducted?

Local Institution - 007-5476 has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer.

Is Local Institution - 007-5476 accredited by Crixeo Health?

Local Institution - 007-5476 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 007-5476?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.